Novozymes Revenue 2011-2024 | NVZMY
Novozymes annual/quarterly revenue history and growth rate from 2011 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Novozymes revenue for the quarter ending June 30, 2024 was $0M, a 100% decline year-over-year.
- Novozymes revenue for the twelve months ending June 30, 2024 was $1.933B, a 22.46% decline year-over-year.
- Novozymes annual revenue for 2024 was $4.148B, a 59.61% increase from 2023.
- Novozymes annual revenue for 2023 was $2.599B, a 4.56% increase from 2022.
- Novozymes annual revenue for 2022 was $2.486B, a 4.49% increase from 2021.
Novozymes Annual Revenue
(Millions of US $) |
| 2024 |
$4,148 |
| 2023 |
$2,599 |
| 2022 |
$2,486 |
| 2021 |
$2,379 |
| 2020 |
$2,147 |
| 2019 |
$2,155 |
| 2018 |
$2,279 |
| 2017 |
$2,207 |
| 2016 |
$2,102 |
| 2015 |
$2,083 |
| 2014 |
$2,221 |
| 2013 |
$2,056 |
| 2012 |
$1,941 |
| 2011 |
$1,965 |
| 2010 |
$1,731 |
Novozymes Quarterly Revenue
(Millions of US $) |
| 2024-06-30 |
|
| 2023-12-31 |
$666 |
| 2023-09-30 |
$651 |
| 2023-06-30 |
$616 |
| 2023-03-31 |
$666 |
| 2022-12-31 |
$623 |
| 2022-09-30 |
$591 |
| 2022-06-30 |
$613 |
| 2022-03-31 |
$659 |
| 2021-12-31 |
$590 |
| 2021-09-30 |
$596 |
| 2021-06-30 |
$580 |
| 2021-03-31 |
$612 |
| 2020-12-31 |
$554 |
| 2020-09-30 |
$539 |
| 2020-06-30 |
$495 |
| 2020-03-31 |
$559 |
| 2019-12-31 |
$552 |
| 2019-09-30 |
$552 |
| 2019-06-30 |
$521 |
| 2019-03-31 |
$530 |
| 2018-12-31 |
$568 |
| 2018-09-30 |
$571 |
| 2018-06-30 |
$560 |
| 2018-03-31 |
$581 |
| 2017-12-31 |
$582 |
| 2017-09-30 |
$566 |
| 2017-06-30 |
$523 |
| 2017-03-31 |
$536 |
| 2016-12-31 |
$539 |
| 2016-09-30 |
$509 |
| 2016-06-30 |
$521 |
| 2016-03-31 |
$533 |
| 2015-12-31 |
$507 |
| 2015-09-30 |
$525 |
| 2015-06-30 |
$511 |
| 2015-03-31 |
$515 |
| 2014-12-31 |
$496 |
| 2014-09-30 |
$541 |
| 2014-06-30 |
$549 |
| 2014-03-31 |
$562 |
| 2013-12-31 |
$534 |
| 2013-09-30 |
$543 |
| 2013-06-30 |
$542 |
| 2013-03-31 |
$497 |
| 2012-12-31 |
$489 |
| 2012-09-30 |
$477 |
| 2012-06-30 |
$471 |
| 2012-03-31 |
$485 |
| 2011-12-31 |
$461 |
| 2011-09-30 |
$511 |
| 2011-06-30 |
$490 |
| 2011-03-31 |
$493 |
| 2010-12-31 |
$438 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$35.010B |
$4.149B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
